Guardant Health (GH) Cash from Investing Activities (2017 - 2026)

Guardant Health has reported Cash from Investing Activities for 10 years, with the latest figure at $101.5 million in Q2 2026.

• Quarterly Cash from Investing Activities rose 1052.89% year-over-year to $101.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$118.5 million (down 1596.92% YoY) and the FY2025 annual result came in at -$627.2 million, down 140.02% from the prior year.
• Cash from Investing Activities fell to $101.5 million in Q2 2026 per GH's latest filing, from $699.4 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $699.4 million in Q1 2026 and troughed at -$905.1 million in Q4 2025.
• A 5-year average of $50.1 million and a median of $34.7 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities slumped 8695.13% in 2025, then jumped 1052.89% in 2026.
• Over 5 years, Cash from Investing Activities stood at $70.6 million in 2022, then surged by 839.38% to $663.5 million in 2023, then slumped by 98.41% to $10.5 million in 2024, then plunged by 8695.13% to -$905.1 million in 2025, then surged by 111.21% to $101.5 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $101.5 million, $699.4 million, and -$905.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.